Cargando…
The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage
Dengue virus (DENV) poses a significant global health challenge, with millions of cases each year. Developing effective antiviral drugs against DENV remains a major hurdle. Varenicline is a medication used to aid smoking cessation, with anti-inflammatory and antioxidant effects. In this study, varen...
Autores principales: | Lin, Ching-Lin, Kiu, Yan-Tung, Kan, Ju-Ying, Chang, Yu-Jen, Hung, Ping-Yi, Lu, Chih-Hao, Lin, Wen-Ling, Hsieh, Yow-Wen, Kao, Jung-Yie, Hu, Nien-Jen, Lin, Cheng-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604274/ https://www.ncbi.nlm.nih.gov/pubmed/37893127 http://dx.doi.org/10.3390/biomedicines11102754 |
Ejemplares similares
-
Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity
por: Hour, Mann-Jen, et al.
Publicado: (2022) -
Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry
por: Kuo, Yu-Ting, et al.
Publicado: (2020) -
Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1
por: Chen, Wei-Chun, et al.
Publicado: (2018) -
Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents
por: Lin, Chun-Kuang, et al.
Publicado: (2017) -
Dengue Virus Entry as Target for Antiviral Therapy
por: Alen, Marijke M. F., et al.
Publicado: (2012)